Gregory M. Glenn, President, R&D at NOVAVAX INC (NVAX), sold 16,847 shares at $142.12 ($2.3M) on 2021-05-19, disclosed to the SEC on 2021-05-19.
Open-market sale of $2.3M NVAX by President, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $131.50 | 1,000 | $132K | 5.7% |
| 2 | $133.10 | 1,348 | $179K | 7.8% |
| 3 | $133.10 | 1,348 | $179K | 7.8% |
| 4 | $135.06 | 3,364 | $454K | 19.7% |
| 5 | $135.06 | 3,364 | $454K | 19.7% |
| 6 | $140.16 | 205 |
| $29K |
| 1.2% |
| 7 | $140.16 | 2,229 | $312K | 13.5% |
| 8 | $138.29 | 62 | $9K | 0.4% |
| 9 | $140.04 | 89 | $12K | 0.5% |
| 10 | $141.23 | 1,018 | $144K | 6.2% |
| 11 | $141.23 | 1,018 | $144K | 6.2% |
| 12 | $142.12 | 586 | $83K | 3.6% |
| 13 | $142.12 | 586 | $83K | 3.6% |
| 14 | $143.62 | 298 | $43K | 1.9% |
| 15 | $144.36 | 162 | $23K | 1.0% |
| 16 | $145.83 | 170 | $25K | 1.1% |
| Total | $136.90 avg | 16,847 | $2.3M | 100% |
| Filing → |
| NVAX | SELL | 2021-12-09 | $1.6M | — | Filing → |
| NVAX | SELL | 2021-12-02 | $3.2M | — | Filing → |
| NVAX | SELL | 2021-11-30 | $719K | — | Filing → |